Was the FDA Too Quick Approving Test for Opioid Addiction Risk?
FRIDAY, April 5, 2024 (HealthDay News) — A test to gauge if it’s safe to prescribe a patient an addictive opioid may have been approved too soon by the U.S. Food and Drug Administration, claims a letter sent to the agency by a group of experts. The test, called AvertD,Continue Reading